Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 First molecular characterization of fluoroquinolone resistance in Aerococcus spp.

Literature DB >> 21078934

First molecular characterization of fluoroquinolone resistance in Aerococcus spp.

Vincent Cattoir, Alfred Kobal, Patrick Legrand.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2010 PMID： 21078934 PMCID： PMC3019681 DOI： 10.1128/AAC.01065-10

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

11 in total

1. Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season.

Authors: M E Jones; D F Sahm; N Martin; S Scheuring; P Heisig; C Thornsberry; K Köhrer; F J Schmitz
Journal: Antimicrob Agents Chemother Date: 2000-02 Impact factor: 5.191

2. Nonmolecular test for detection of low-level resistance to fluoroquinolones in Streptococcus pneumoniae.

Authors: Emmanuelle Varon; Serge Houssaye; Sophie Grondin; Laurent Gutmann
Journal: Antimicrob Agents Chemother Date: 2006-02 Impact factor: 5.191

Review 3. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance.

Authors: F-J Schmitz; P G Higgins; S Mayer; A C Fluit; A Dalhoff
Journal: Eur J Clin Microbiol Infect Dis Date: 2002-09-07 Impact factor: 3.267

4. In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin.

Authors: R Skov; J J Christensen; B Korner; N Frimodt-Møller; F Espersen
Journal: J Antimicrob Chemother Date: 2001-11 Impact factor: 5.790

5. Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.

Authors: Heather J Adam; Kristen N Schurek; Kimberly A Nichol; Chris J Hoban; Trish J Baudry; Nancy M Laing; Daryl J Hoban; George G Zhanel
Journal: Antimicrob Agents Chemother Date: 2006-11-06 Impact factor: 5.191

Review 6. Fluoroquinolone resistance among Gram-positive cocci.

Authors: David C Hooper
Journal: Lancet Infect Dis Date: 2002-09 Impact factor: 25.071

7. Molecular characterization of quinolone resistance-determining regions and their correlation with serotypes and genotypes among Streptococcus pneumoniae isolates in Japan.

Authors: M Osawa; Y Ito; T Ishida; S Imai; S Ichiyama; M Mishima
Journal: Eur J Clin Microbiol Infect Dis Date: 2009-11-24 Impact factor: 3.267

8. First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.

Authors: Yoshiaki Kawamura; Hiromitsu Fujiwara; Noriko Mishima; Yuko Tanaka; Ayako Tanimoto; Shiro Ikawa; Youko Itoh; Takayuki Ezaki
Journal: Antimicrob Agents Chemother Date: 2003-11 Impact factor: 5.191

9. Phenotypic description and antimicrobial susceptibilities of Aerococcus sanguinicola isolates from human clinical samples.

Authors: Richard Facklam; Marguerite Lovgren; Patricia Lynn Shewmaker; Gregory Tyrrell
Journal: J Clin Microbiol Date: 2003-06 Impact factor: 5.948

10. In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients.

Authors: Kenneth V I Rolston; Susan Frisbee-Hume; Barbara LeBlanc; Harriet Streeter; Dah Hsi Ho
Journal: Diagn Microbiol Infect Dis Date: 2003-10 Impact factor: 2.803

6 in total

First molecular characterization of fluoroquinolone resistance in Aerococcus spp.

1. Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season.

2. Nonmolecular test for detection of low-level resistance to fluoroquinolones in Streptococcus pneumoniae.

Review 3. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance.

4. In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin.

5. Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.

Review 6. Fluoroquinolone resistance among Gram-positive cocci.

7. Molecular characterization of quinolone resistance-determining regions and their correlation with serotypes and genotypes among Streptococcus pneumoniae isolates in Japan.

8. First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.

9. Phenotypic description and antimicrobial susceptibilities of Aerococcus sanguinicola isolates from human clinical samples.

10. In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients.

1. Aerococcus urinae, a rare cause of infective endocarditis.

2. In vitro antimicrobial susceptibility of Aerococcus urinae.

3. A population-based study of aerococcal bacteraemia in the MALDI-TOF MS-era.

4. Necrotizing Urethritis due to Aerococcus urinae.

5. Bacteremia with Aerococcus sanguinicola: Case Series with Characterization of Virulence Properties.

6. First case of pregnant women bacteraemia and probable early-onset neonatal infection due to Aerococcus urinae.